Current literature supports ibuprofen and APAP are the most commonly used analgesics in the
pediatric ED for acute traumatic/non-traumatic pain. However, the analgesic benefits of
combination ibuprofen and APAP in this specific setting does not exist, but instead only as
it applies to pediatric patients with postoperative pain. Thus, we have designed a
double-blind, randomized, controlled clinical trial to evaluate analgesic efficacy, safety
and feasibility of combination therapy to potentially broaden its clinical application in the
pediatric ED. The investigators' hypothesize that combination oral ibuprofen and APAP therapy
is superior to either drug alone and is an excellent analgesic modality for controlling acute
traumatic/non-traumatic pain in the pediatric ED.